We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management.
- Authors
Simonetti, Giacomo D; Santoro, Laura; Ferrarini, Alessandra; Crosazzo-Franscini, Laura; Fossali, Emilio; Bianchetti, Mario G; CHILD Project
- Abstract
A variety of chronic kidney diseases tend to progress towards end-stage kidney disease. Progression is largely due to factors unrelated to the initial disease, including systemic hypertension and proteinuria. Drugs that block the renin-angiotensin II-aldosterone system, either ACE inhibitors or angiotensin II receptor antagonists, reduce both BP and proteinuria and appear superior to a more conventional antihypertensive treatment regimen in preventing progression to end-stage kidney disease. The most recent recommendations state that the BP goal in children with chronic kidney disease is the corresponding 90th centile for body height, age, and gender. Since satisfactory BP control is often not achieved, the mnemonic acronym DELTAREPROSI was generated to recall the following tips for the practical management of hypertension and proteinuria in childhood chronic renal parenchymal disease: DEfinition of hypertension and Low blood pressure TArget in REnal disease (90th centile calculated by means of simple formulas), potential of drugs inhibiting the REnin-angiotensin II-aldosterone system in hypertension and PROteinuria, advantages of SImplified treatment regimens and escalating the doses every SIx weeks.
- Publication
Paediatric drugs, 2007, Vol 9, Issue 6, p413
- ISSN
1174-5878
- Publication type
Journal Article
- DOI
10.2165/00148581-200709060-00008